Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Mining Press Releases.
Press releases published on March 2, 2026
Mar. 2, 2026
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
Mar. 2, 2026
GPGI Appoints 30-Year Veteran Robert Domodossola as President and CEO of Husky
Indeterminate
GlobeNewswire
Mar. 2, 2026
CrossAmerica Partners LP Announces President and CEO Transition
Indeterminate
GlobeNewswire
Mar. 2, 2026
BtcDana Group Surpasses 1.5 Million Global Users, Reporting Major Growth and Engagement
Indeterminate
GlobeNewswire
Mar. 2, 2026
Vantry Capital Announces Rebrand and Launch of Probability-Based Corporate FX Risk Platform
Indeterminate
GlobeNewswire
Mar. 2, 2026
Power Solutions International Announces Fourth Quarter and Record Full Year 2025 Financial Results
Indeterminate
GlobeNewswire
Mar. 2, 2026
STMicroelectronics’ sensor and secure wireless technologies support Snapdragon Wear Elite
Indeterminate
GlobeNewswire
Mar. 2, 2026
NATURAL GAS SERVICES GROUP, INC. TO HOST FOURTH-QUARTER AND FULL-YEAR 2025 EARNINGS CONFERENCE CALL
Indeterminate
GlobeNewswire
Mar. 2, 2026
3D Systems Announces Date of Fourth Quarter and Full Year 2025 Financial Results
Indeterminate
GlobeNewswire
Mar. 2, 2026
H2O America Announces Proposed Offering of Common Stock with a Forward Component
Indeterminate
GlobeNewswire
Mar. 2, 2026
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
Mar. 2, 2026
Harrow Announces Q4 and Full-Year 2025 Financial Results and 2026 Financial Guidance
Indeterminate
GlobeNewswire
Mar. 2, 2026
Immuneering to Present at the Leerink Global Healthcare Conference
Indeterminate
GlobeNewswire
Mar. 2, 2026
Mobile Infrastructure Reports Fourth Quarter and Full Year 2025 Financial Results
Indeterminate
GlobeNewswire
Mar. 2, 2026
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
Mar. 2, 2026
Myriad Commercially Launches Precise MRD with Select Community Oncologists
Indeterminate
GlobeNewswire
Mar. 2, 2026
XPO Provides North American LTL Operating Data for February 2026
Indeterminate
GlobeNewswire